Purpose: To determine effects of family conflict mitigation documentary programs on conflicts, autonomic nerve activation (ANA), and happiness of elderly in long-term care hospitals. Methods: This study used a non-equivalent control group with a pretest-posttest design. It was conducted on 39 elderly patients (19 in the experimental group and 20 in the control group) in long-term care hospitals. The experimental group (n = 19) received family conflict mitigation documentary programs. The family conflict mitigation documentary programs consisted of four sessions (40-50 minutes per session). These programs were implemented in small groups, with each group having five elderly. Data were analyzed by sing the conflict checklist, the Oxford Happiness Questionnaire, Chi-square test with Fisher’s exact test, independent t-test, paired t-test, and repeated measure ANOVA using the SPSS/WIN 21.0 program. Results: The participants in the experimental group showed significantly decreased scores of conflict (t = -2.31, p = .028) and the value of sympathetic nervous system activity (t = 8.36, p = .007) compared with those of the control group. The participants in the experimental group showed significantly increased the value of parasympathetic nervous system activity (t = -2.91, p = .008) and scores of happiness (t = 5.46, p < .001). Conclusion The family conflict mitigation documentary programs on conflicts, ANA, and happiness of the elderly in long-term care hospitals are effective intervention programs for mitigating conflicts between elderlies and their families and for improving happiness of the elderly in long-term care hospitals.

Purpose: To determine effects of family conflict mitigation documentary programs on conflicts, autonomic nerve activation (ANA), and happiness of elderly in long-term care hospitals. Methods: This study used a non-equivalent control group with a pretest-posttest design. It was conducted on 39 elderly patients (19 in the experimental group and 20 in the control group) in long-term care hospitals. The experimental group (n = 19) received family conflict mitigation documentary programs. The family conflict mitigation documentary programs consisted of four sessions (40-50 minutes per session). These programs were implemented in small groups, with each group having five elderly. Data were analyzed by sing the conflict checklist, the Oxford Happiness Questionnaire, Chi-square test with Fisher’s exact test, independent t-test, paired t-test, and repeated measure ANOVA using the SPSS/WIN 21.0 program. Results: The participants in the experimental group showed significantly decreased scores of conflict (t = -2.31, p = .028) and the value of sympathetic nervous system activity (t = 8.36, p = .007) compared with those of the control group. The participants in the experimental group showed significantly increased the value of parasympathetic nervous system activity (t = -2.91, p = .008) and scores of happiness (t = 5.46, p < .001). Conclusion The family conflict mitigation documentary programs on conflicts, ANA, and happiness of the elderly in long-term care hospitals are effective intervention programs for mitigating conflicts between elderlies and their families and for improving happiness of the elderly in long-term care hospitals.

Objective: Hypoxic-ischemic encephalopathy (HIE) frequently leads to neurological complications, such as seizures and developmental disorders. In addition to these challenges, many infants with HIE experience multi-organ dysfunction, and HIE is a major cause of acute kidney injury (AKI) during the neonatal period. This study aimed to investigate the risk factors for AKI in neonates treated with therapeutic hypothermia (TH) for HIE. Methods: We retrospectively reviewed neonates who received TH for HIE at a single center between January 2015 and August 2024. AKI was defined according to the neonatal modified Kidney Disease Improving Global Outcome criteria. Initial blood gas analysis, seizures, severity of HIE, neurologic studies, and mortality were compared between infants with and without AKI. Results: Among 288 neonates with HIE, TH was performed on 60 neonates, of which 3 were ex cluded, resulting in a total of 57 neonates. A total of 25 patients (43.9%) developed AKI, of whom 10 had stage 1 AKI, 6 had stage 2 AKI, and 9 had stage 3 AKI. In stage 3 AKI, one patient (1.8%) needed renal replacement therapy. Initial pH (P=0.040) and base excess (BE) (P=0.008) were significantly lower in the AKI group compared to the non-AKI group. AKI patients had a significantly higher rate of severe HIE (P=0.018), convulsions (P=0.022), and mortality (P=0.017). In logistic regression analysis, low initial BE and the presence of convulsion were independently associated with an increased risk of AKI, with odds ratios of 1.16 and 3.95, respectively. Conclusion AKI remains common in neonates with HIE treated with TH. Low BE and convulsion were identified as independent risk factors for the development of AKI.

Objective: Hypoxic-ischemic encephalopathy (HIE) frequently leads to neurological complications, such as seizures and developmental disorders. In addition to these challenges, many infants with HIE experience multi-organ dysfunction, and HIE is a major cause of acute kidney injury (AKI) during the neonatal period. This study aimed to investigate the risk factors for AKI in neonates treated with therapeutic hypothermia (TH) for HIE. Methods: We retrospectively reviewed neonates who received TH for HIE at a single center between January 2015 and August 2024. AKI was defined according to the neonatal modified Kidney Disease Improving Global Outcome criteria. Initial blood gas analysis, seizures, severity of HIE, neurologic studies, and mortality were compared between infants with and without AKI. Results: Among 288 neonates with HIE, TH was performed on 60 neonates, of which 3 were ex cluded, resulting in a total of 57 neonates. A total of 25 patients (43.9%) developed AKI, of whom 10 had stage 1 AKI, 6 had stage 2 AKI, and 9 had stage 3 AKI. In stage 3 AKI, one patient (1.8%) needed renal replacement therapy. Initial pH (P=0.040) and base excess (BE) (P=0.008) were significantly lower in the AKI group compared to the non-AKI group. AKI patients had a significantly higher rate of severe HIE (P=0.018), convulsions (P=0.022), and mortality (P=0.017). In logistic regression analysis, low initial BE and the presence of convulsion were independently associated with an increased risk of AKI, with odds ratios of 1.16 and 3.95, respectively. Conclusion AKI remains common in neonates with HIE treated with TH. Low BE and convulsion were identified as independent risk factors for the development of AKI.

Objective: Hypoxic-ischemic encephalopathy (HIE) frequently leads to neurological complications, such as seizures and developmental disorders. In addition to these challenges, many infants with HIE experience multi-organ dysfunction, and HIE is a major cause of acute kidney injury (AKI) during the neonatal period. This study aimed to investigate the risk factors for AKI in neonates treated with therapeutic hypothermia (TH) for HIE. Methods: We retrospectively reviewed neonates who received TH for HIE at a single center between January 2015 and August 2024. AKI was defined according to the neonatal modified Kidney Disease Improving Global Outcome criteria. Initial blood gas analysis, seizures, severity of HIE, neurologic studies, and mortality were compared between infants with and without AKI. Results: Among 288 neonates with HIE, TH was performed on 60 neonates, of which 3 were ex cluded, resulting in a total of 57 neonates. A total of 25 patients (43.9%) developed AKI, of whom 10 had stage 1 AKI, 6 had stage 2 AKI, and 9 had stage 3 AKI. In stage 3 AKI, one patient (1.8%) needed renal replacement therapy. Initial pH (P=0.040) and base excess (BE) (P=0.008) were significantly lower in the AKI group compared to the non-AKI group. AKI patients had a significantly higher rate of severe HIE (P=0.018), convulsions (P=0.022), and mortality (P=0.017). In logistic regression analysis, low initial BE and the presence of convulsion were independently associated with an increased risk of AKI, with odds ratios of 1.16 and 3.95, respectively. Conclusion AKI remains common in neonates with HIE treated with TH. Low BE and convulsion were identified as independent risk factors for the development of AKI.

Objective: Hypoxic-ischemic encephalopathy (HIE) frequently leads to neurological complications, such as seizures and developmental disorders. In addition to these challenges, many infants with HIE experience multi-organ dysfunction, and HIE is a major cause of acute kidney injury (AKI) during the neonatal period. This study aimed to investigate the risk factors for AKI in neonates treated with therapeutic hypothermia (TH) for HIE. Methods: We retrospectively reviewed neonates who received TH for HIE at a single center between January 2015 and August 2024. AKI was defined according to the neonatal modified Kidney Disease Improving Global Outcome criteria. Initial blood gas analysis, seizures, severity of HIE, neurologic studies, and mortality were compared between infants with and without AKI. Results: Among 288 neonates with HIE, TH was performed on 60 neonates, of which 3 were ex cluded, resulting in a total of 57 neonates. A total of 25 patients (43.9%) developed AKI, of whom 10 had stage 1 AKI, 6 had stage 2 AKI, and 9 had stage 3 AKI. In stage 3 AKI, one patient (1.8%) needed renal replacement therapy. Initial pH (P=0.040) and base excess (BE) (P=0.008) were significantly lower in the AKI group compared to the non-AKI group. AKI patients had a significantly higher rate of severe HIE (P=0.018), convulsions (P=0.022), and mortality (P=0.017). In logistic regression analysis, low initial BE and the presence of convulsion were independently associated with an increased risk of AKI, with odds ratios of 1.16 and 3.95, respectively. Conclusion AKI remains common in neonates with HIE treated with TH. Low BE and convulsion were identified as independent risk factors for the development of AKI.

Objective: Hypoxic-ischemic encephalopathy (HIE) frequently leads to neurological complications, such as seizures and developmental disorders. In addition to these challenges, many infants with HIE experience multi-organ dysfunction, and HIE is a major cause of acute kidney injury (AKI) during the neonatal period. This study aimed to investigate the risk factors for AKI in neonates treated with therapeutic hypothermia (TH) for HIE. Methods: We retrospectively reviewed neonates who received TH for HIE at a single center between January 2015 and August 2024. AKI was defined according to the neonatal modified Kidney Disease Improving Global Outcome criteria. Initial blood gas analysis, seizures, severity of HIE, neurologic studies, and mortality were compared between infants with and without AKI. Results: Among 288 neonates with HIE, TH was performed on 60 neonates, of which 3 were ex cluded, resulting in a total of 57 neonates. A total of 25 patients (43.9%) developed AKI, of whom 10 had stage 1 AKI, 6 had stage 2 AKI, and 9 had stage 3 AKI. In stage 3 AKI, one patient (1.8%) needed renal replacement therapy. Initial pH (P=0.040) and base excess (BE) (P=0.008) were significantly lower in the AKI group compared to the non-AKI group. AKI patients had a significantly higher rate of severe HIE (P=0.018), convulsions (P=0.022), and mortality (P=0.017). In logistic regression analysis, low initial BE and the presence of convulsion were independently associated with an increased risk of AKI, with odds ratios of 1.16 and 3.95, respectively. Conclusion AKI remains common in neonates with HIE treated with TH. Low BE and convulsion were identified as independent risk factors for the development of AKI.

No abstract available.
Body Weight* ; Cholesterol*

No abstract available.
Brain* ; Tomography, Emission-Computed, Single-Photon*

No abstract available.
Pregnancy* ; Round Ligament of Uterus*